nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—SLC15A2—melanoma	0.744	1	CbGaD
Tranexamic Acid—PLG—appendage—melanoma	0.016	0.266	CbGeAlD
Tranexamic Acid—PLG—endothelium—melanoma	0.00964	0.161	CbGeAlD
Tranexamic Acid—PLG—blood vessel—melanoma	0.00889	0.148	CbGeAlD
Tranexamic Acid—PLG—neck—melanoma	0.00636	0.106	CbGeAlD
Tranexamic Acid—PLG—eye—melanoma	0.00473	0.0788	CbGeAlD
Tranexamic Acid—PLG—retina—melanoma	0.00469	0.0781	CbGeAlD
Tranexamic Acid—PLG—skin of body—melanoma	0.00411	0.0685	CbGeAlD
Tranexamic Acid—Hemiparesis—Temozolomide—melanoma	0.00365	0.0534	CcSEcCtD
Tranexamic Acid—PLG—head—melanoma	0.00268	0.0447	CbGeAlD
Tranexamic Acid—Thromboembolic event—Docetaxel—melanoma	0.00189	0.0276	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Vemurafenib—melanoma	0.00151	0.0222	CcSEcCtD
Tranexamic Acid—SLC15A2—retina—melanoma	0.0015	0.025	CbGeAlD
Tranexamic Acid—Deep vein thrombosis—Temozolomide—melanoma	0.00126	0.0184	CcSEcCtD
Tranexamic Acid—Embolism—Temozolomide—melanoma	0.00119	0.0174	CcSEcCtD
Tranexamic Acid—Atrial fibrillation—Vemurafenib—melanoma	0.00115	0.0168	CcSEcCtD
Tranexamic Acid—Digestion impaired—Temozolomide—melanoma	0.00114	0.0167	CcSEcCtD
Tranexamic Acid—SLC15A2—head—melanoma	0.000859	0.0143	CbGeAlD
Tranexamic Acid—Deep vein thrombosis—Docetaxel—melanoma	0.000835	0.0122	CcSEcCtD
Tranexamic Acid—Embolism—Docetaxel—melanoma	0.000792	0.0116	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Carmustine—melanoma	0.000791	0.0116	CcSEcCtD
Tranexamic Acid—Respiratory failure—Temozolomide—melanoma	0.000778	0.0114	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Temozolomide—melanoma	0.000774	0.0113	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Temozolomide—melanoma	0.000764	0.0112	CcSEcCtD
Tranexamic Acid—Eye disorder—Vemurafenib—melanoma	0.000702	0.0103	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Vemurafenib—melanoma	0.000697	0.0102	CcSEcCtD
Tranexamic Acid—Dermatitis atopic—Docetaxel—melanoma	0.000687	0.0101	CcSEcCtD
Tranexamic Acid—Angiopathy—Vemurafenib—melanoma	0.000681	0.00998	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Vemurafenib—melanoma	0.000677	0.00991	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Bleomycin—melanoma	0.000671	0.00983	CcSEcCtD
Tranexamic Acid—Swelling—Carmustine—melanoma	0.000651	0.00953	CcSEcCtD
Tranexamic Acid—Back pain—Vemurafenib—melanoma	0.000632	0.00926	CcSEcCtD
Tranexamic Acid—Myocardial ischaemia—Docetaxel—melanoma	0.000632	0.00926	CcSEcCtD
Tranexamic Acid—SLC15A2—lymph node—melanoma	0.000601	0.01	CbGeAlD
Tranexamic Acid—Arthralgia—Vemurafenib—melanoma	0.000557	0.00815	CcSEcCtD
Tranexamic Acid—Myalgia—Vemurafenib—melanoma	0.000557	0.00815	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Vemurafenib—melanoma	0.000534	0.00781	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Vemurafenib—melanoma	0.000523	0.00766	CcSEcCtD
Tranexamic Acid—Respiratory failure—Docetaxel—melanoma	0.000518	0.00758	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Docetaxel—melanoma	0.000508	0.00744	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Bleomycin—melanoma	0.0005	0.00732	CcSEcCtD
Tranexamic Acid—Hypotension—Vemurafenib—melanoma	0.000499	0.0073	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Bleomycin—melanoma	0.000497	0.00728	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000486	0.00712	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Vemurafenib—melanoma	0.000461	0.00675	CcSEcCtD
Tranexamic Acid—Fatigue—Vemurafenib—melanoma	0.00046	0.00674	CcSEcCtD
Tranexamic Acid—Haemoglobin—Bleomycin—melanoma	0.000457	0.0067	CcSEcCtD
Tranexamic Acid—Haemorrhage—Bleomycin—melanoma	0.000455	0.00666	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Docetaxel—melanoma	0.000452	0.00663	CcSEcCtD
Tranexamic Acid—Renal failure—Carmustine—melanoma	0.000435	0.00637	CcSEcCtD
Tranexamic Acid—Flushing—Bleomycin—melanoma	0.000422	0.00618	CcSEcCtD
Tranexamic Acid—Swelling—Docetaxel—melanoma	0.000418	0.00612	CcSEcCtD
Tranexamic Acid—Sinusitis—Temozolomide—melanoma	0.000401	0.00587	CcSEcCtD
Tranexamic Acid—Haemoglobin—Carmustine—melanoma	0.000399	0.00585	CcSEcCtD
Tranexamic Acid—Haemorrhage—Carmustine—melanoma	0.000397	0.00582	CcSEcCtD
Tranexamic Acid—Flushing—Dactinomycin—melanoma	0.000394	0.00577	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vemurafenib—melanoma	0.000393	0.00576	CcSEcCtD
Tranexamic Acid—Visual disturbance—Docetaxel—melanoma	0.000389	0.0057	CcSEcCtD
Tranexamic Acid—Atrial fibrillation—Docetaxel—melanoma	0.000389	0.0057	CcSEcCtD
Tranexamic Acid—Haemoglobin—Temozolomide—melanoma	0.000386	0.00565	CcSEcCtD
Tranexamic Acid—Haemorrhage—Temozolomide—melanoma	0.000384	0.00562	CcSEcCtD
Tranexamic Acid—Asthenia—Vemurafenib—melanoma	0.000383	0.00561	CcSEcCtD
Tranexamic Acid—Visual impairment—Carmustine—melanoma	0.000383	0.0056	CcSEcCtD
Tranexamic Acid—Eye disorder—Carmustine—melanoma	0.000371	0.00544	CcSEcCtD
Tranexamic Acid—Visual impairment—Temozolomide—melanoma	0.00037	0.00542	CcSEcCtD
Tranexamic Acid—Flushing—Carmustine—melanoma	0.000369	0.0054	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Bleomycin—melanoma	0.000368	0.00538	CcSEcCtD
Tranexamic Acid—Anaemia—Bleomycin—melanoma	0.000366	0.00536	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vemurafenib—melanoma	0.000365	0.00535	CcSEcCtD
Tranexamic Acid—Migraine—Docetaxel—melanoma	0.000363	0.00532	CcSEcCtD
Tranexamic Acid—Eye disorder—Temozolomide—melanoma	0.000359	0.00525	CcSEcCtD
Tranexamic Acid—Malaise—Bleomycin—melanoma	0.000357	0.00523	CcSEcCtD
Tranexamic Acid—Flushing—Temozolomide—melanoma	0.000356	0.00522	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Temozolomide—melanoma	0.000356	0.00522	CcSEcCtD
Tranexamic Acid—Arrhythmia—Carmustine—melanoma	0.000355	0.0052	CcSEcCtD
Tranexamic Acid—Dizziness—Vemurafenib—melanoma	0.000353	0.00517	CcSEcCtD
Tranexamic Acid—Angiopathy—Temozolomide—melanoma	0.000348	0.0051	CcSEcCtD
Tranexamic Acid—Immune system disorder—Temozolomide—melanoma	0.000347	0.00508	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Temozolomide—melanoma	0.000346	0.00507	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Dactinomycin—melanoma	0.000343	0.00502	CcSEcCtD
Tranexamic Acid—Anaemia—Dactinomycin—melanoma	0.000341	0.005	CcSEcCtD
Tranexamic Acid—Vomiting—Vemurafenib—melanoma	0.000339	0.00497	CcSEcCtD
Tranexamic Acid—Chest pain—Bleomycin—melanoma	0.000337	0.00494	CcSEcCtD
Tranexamic Acid—Myalgia—Bleomycin—melanoma	0.000337	0.00494	CcSEcCtD
Tranexamic Acid—Back pain—Carmustine—melanoma	0.000334	0.0049	CcSEcCtD
Tranexamic Acid—Headache—Vemurafenib—melanoma	0.000334	0.00489	CcSEcCtD
Tranexamic Acid—Discomfort—Bleomycin—melanoma	0.000333	0.00488	CcSEcCtD
Tranexamic Acid—Malaise—Dactinomycin—melanoma	0.000333	0.00488	CcSEcCtD
Tranexamic Acid—Cramp muscle—Docetaxel—melanoma	0.000332	0.00487	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK1—melanoma	0.000332	0.0026	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—GNAQ—melanoma	0.00033	0.00258	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—NFKB1—melanoma	0.000325	0.00255	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Bleomycin—melanoma	0.000323	0.00473	CcSEcCtD
Tranexamic Acid—Back pain—Temozolomide—melanoma	0.000323	0.00473	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ADAMTS13—melanoma	0.000322	0.00252	CbGpPWpGaD
Tranexamic Acid—Anaemia—Carmustine—melanoma	0.00032	0.00468	CcSEcCtD
Tranexamic Acid—Nausea—Vemurafenib—melanoma	0.000317	0.00464	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—melanoma	0.000316	0.00247	CbGpPWpGaD
Tranexamic Acid—Myalgia—Dactinomycin—melanoma	0.000314	0.00461	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB4—melanoma	0.000314	0.00246	CbGpPWpGaD
Tranexamic Acid—Discomfort—Dactinomycin—melanoma	0.000311	0.00455	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—melanoma	0.000311	0.00244	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Docetaxel—melanoma	0.000311	0.00455	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IFNG—melanoma	0.00031	0.00243	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—BSG—melanoma	0.00031	0.00243	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Temozolomide—melanoma	0.00031	0.00454	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SYK—melanoma	0.00031	0.00243	CbGpPWpGaD
Tranexamic Acid—Anaemia—Temozolomide—melanoma	0.000309	0.00452	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT3—melanoma	0.000304	0.00238	CbGpPWpGaD
Tranexamic Acid—Hypotension—Bleomycin—melanoma	0.000302	0.00442	CcSEcCtD
Tranexamic Acid—Malaise—Temozolomide—melanoma	0.000301	0.00441	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CD86—melanoma	0.000301	0.00236	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IFNA5—melanoma	0.0003	0.00235	CbGpPWpGaD
Tranexamic Acid—Convulsion—Carmustine—melanoma	0.0003	0.00439	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—melanoma	0.000297	0.00233	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Bleomycin—melanoma	0.000295	0.00431	CcSEcCtD
Tranexamic Acid—Myalgia—Carmustine—melanoma	0.000294	0.00431	CcSEcCtD
Tranexamic Acid—Chest pain—Carmustine—melanoma	0.000294	0.00431	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—FGF1—melanoma	0.000292	0.00229	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FLNA—melanoma	0.000291	0.00229	CbGpPWpGaD
Tranexamic Acid—Convulsion—Temozolomide—melanoma	0.000289	0.00424	CcSEcCtD
Tranexamic Acid—Dyspnoea—Bleomycin—melanoma	0.000288	0.00422	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—melanoma	0.000288	0.00226	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000287	0.00225	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGA4—melanoma	0.000286	0.00224	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CD44—melanoma	0.000286	0.00224	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Temozolomide—melanoma	0.000284	0.00417	CcSEcCtD
Tranexamic Acid—Myalgia—Temozolomide—melanoma	0.000284	0.00417	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PDGFRA—melanoma	0.000283	0.00221	CbGpPWpGaD
Tranexamic Acid—Discomfort—Temozolomide—melanoma	0.000281	0.00412	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Docetaxel—melanoma	0.00028	0.0041	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PRKCA—melanoma	0.00028	0.00219	CbGpPWpGaD
Tranexamic Acid—Renal failure—Docetaxel—melanoma	0.000279	0.00409	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Docetaxel—melanoma	0.000279	0.00408	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000275	0.00402	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—SPP1—melanoma	0.000274	0.00215	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CASP3—melanoma	0.000274	0.00215	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MAP2K2—melanoma	0.000273	0.00214	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Temozolomide—melanoma	0.000273	0.00399	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Temozolomide—melanoma	0.000267	0.00392	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Bleomycin—melanoma	0.000266	0.0039	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGAV—melanoma	0.000264	0.00207	CbGpPWpGaD
Tranexamic Acid—Hypotension—Carmustine—melanoma	0.000264	0.00386	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CLU—melanoma	0.000264	0.00207	CbGpPWpGaD
Tranexamic Acid—Fatigue—Dactinomycin—melanoma	0.00026	0.00381	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—melanoma	0.000259	0.00203	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—NFKB1—melanoma	0.000258	0.00202	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RHOB—melanoma	0.000258	0.00202	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Carmustine—melanoma	0.000257	0.00376	CcSEcCtD
Tranexamic Acid—Haemoglobin—Docetaxel—melanoma	0.000257	0.00376	CcSEcCtD
Tranexamic Acid—Haemorrhage—Docetaxel—melanoma	0.000255	0.00374	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—melanoma	0.000253	0.00198	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—melanoma	0.000253	0.00198	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—HGF—melanoma	0.000253	0.00198	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Carmustine—melanoma	0.000252	0.00368	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—melanoma	0.000251	0.00197	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CSF2—melanoma	0.00025	0.00196	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Dactinomycin—melanoma	0.000248	0.00364	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Temozolomide—melanoma	0.000248	0.00364	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Dactinomycin—melanoma	0.000247	0.00361	CcSEcCtD
Tranexamic Acid—Visual impairment—Docetaxel—melanoma	0.000246	0.0036	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Carmustine—melanoma	0.000244	0.00357	CcSEcCtD
Tranexamic Acid—Dyspnoea—Temozolomide—melanoma	0.000243	0.00356	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—melanoma	0.000241	0.00189	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Temozolomide—melanoma	0.00024	0.00352	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—RPS3—melanoma	0.00024	0.00188	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGB1—melanoma	0.00024	0.00188	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PRKCA—melanoma	0.000239	0.00188	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ITGB3—melanoma	0.000239	0.00188	CbGpPWpGaD
Tranexamic Acid—Eye disorder—Docetaxel—melanoma	0.000239	0.00349	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dactinomycin—melanoma	0.000238	0.00349	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Bleomycin—melanoma	0.000238	0.00349	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Docetaxel—melanoma	0.000237	0.00347	CcSEcCtD
Tranexamic Acid—Flushing—Docetaxel—melanoma	0.000237	0.00347	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Temozolomide—melanoma	0.000235	0.00345	CcSEcCtD
Tranexamic Acid—Fatigue—Temozolomide—melanoma	0.000235	0.00344	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—melanoma	0.000235	0.00184	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Carmustine—melanoma	0.000233	0.00341	CcSEcCtD
Tranexamic Acid—Asthenia—Bleomycin—melanoma	0.000232	0.0034	CcSEcCtD
Tranexamic Acid—Angiopathy—Docetaxel—melanoma	0.000232	0.00339	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—RAC2—melanoma	0.000231	0.00181	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Carmustine—melanoma	0.000231	0.00338	CcSEcCtD
Tranexamic Acid—Immune system disorder—Docetaxel—melanoma	0.000231	0.00338	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Docetaxel—melanoma	0.00023	0.00337	CcSEcCtD
Tranexamic Acid—Arrhythmia—Docetaxel—melanoma	0.000228	0.00334	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VEGFC—melanoma	0.000228	0.00178	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Temozolomide—melanoma	0.000225	0.00329	CcSEcCtD
Tranexamic Acid—Abdominal pain—Carmustine—melanoma	0.000223	0.00327	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Temozolomide—melanoma	0.000223	0.00327	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TP53—melanoma	0.000223	0.00175	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—melanoma	0.000222	0.00174	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Dactinomycin—melanoma	0.000222	0.00325	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAC1—melanoma	0.000222	0.00174	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CD80—melanoma	0.000219	0.00172	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KIT—melanoma	0.000219	0.00172	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGF—melanoma	0.000217	0.0017	CbGpPWpGaD
Tranexamic Acid—Asthenia—Dactinomycin—melanoma	0.000216	0.00317	CcSEcCtD
Tranexamic Acid—Abdominal pain—Temozolomide—melanoma	0.000216	0.00316	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—DRAP1—melanoma	0.000215	0.00169	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYO7A—melanoma	0.000215	0.00169	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—melanoma	0.000215	0.00169	CbGpPWpGaD
Tranexamic Acid—Back pain—Docetaxel—melanoma	0.000215	0.00315	CcSEcCtD
Tranexamic Acid—Muscle spasms—Docetaxel—melanoma	0.000214	0.00313	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000209	0.00164	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Carmustine—melanoma	0.000208	0.00304	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—PRKCA—melanoma	0.000208	0.00163	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGB3—melanoma	0.000208	0.00163	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Dactinomycin—melanoma	0.000206	0.00302	CcSEcCtD
Tranexamic Acid—Vomiting—Bleomycin—melanoma	0.000206	0.00301	CcSEcCtD
Tranexamic Acid—Anaemia—Docetaxel—melanoma	0.000205	0.00301	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL6—melanoma	0.000204	0.0016	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SPP1—melanoma	0.000204	0.0016	CbGpPWpGaD
Tranexamic Acid—Asthenia—Carmustine—melanoma	0.000202	0.00296	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Temozolomide—melanoma	0.000201	0.00294	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—melanoma	0.000201	0.00157	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—F2R—melanoma	0.0002	0.00157	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SPARC—melanoma	0.0002	0.00157	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FN1—melanoma	0.000196	0.00154	CbGpPWpGaD
Tranexamic Acid—Asthenia—Temozolomide—melanoma	0.000196	0.00287	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Docetaxel—melanoma	0.000195	0.00286	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAP2K1—melanoma	0.000194	0.00152	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Carmustine—melanoma	0.000193	0.00283	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CD—melanoma	0.000193	0.00151	CbGpPWpGaD
Tranexamic Acid—Convulsion—Docetaxel—melanoma	0.000193	0.00282	CcSEcCtD
Tranexamic Acid—Nausea—Bleomycin—melanoma	0.000192	0.00281	CcSEcCtD
Tranexamic Acid—Vomiting—Dactinomycin—melanoma	0.000192	0.00281	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00019	0.00149	CbGpPWpGaD
Tranexamic Acid—Chest pain—Docetaxel—melanoma	0.000189	0.00277	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—melanoma	0.000189	0.00277	CcSEcCtD
Tranexamic Acid—Myalgia—Docetaxel—melanoma	0.000189	0.00277	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—melanoma	0.000188	0.00147	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HSPA5—melanoma	0.000187	0.00147	CbGpPWpGaD
Tranexamic Acid—Dizziness—Carmustine—melanoma	0.000187	0.00273	CcSEcCtD
Tranexamic Acid—Diarrhoea—Temozolomide—melanoma	0.000187	0.00273	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP1—melanoma	0.000186	0.00146	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—EGF—melanoma	0.000185	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGF2—melanoma	0.000184	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TAS2R60—melanoma	0.000183	0.00143	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GAB2—melanoma	0.000183	0.00143	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GNA11—melanoma	0.000183	0.00143	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—melanoma	0.000182	0.00142	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Docetaxel—melanoma	0.000181	0.00266	CcSEcCtD
Tranexamic Acid—Dizziness—Temozolomide—melanoma	0.00018	0.00264	CcSEcCtD
Tranexamic Acid—Vomiting—Carmustine—melanoma	0.000179	0.00263	CcSEcCtD
Tranexamic Acid—Nausea—Dactinomycin—melanoma	0.000179	0.00262	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Docetaxel—melanoma	0.000178	0.0026	CcSEcCtD
Tranexamic Acid—Headache—Carmustine—melanoma	0.000177	0.00259	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—KDR—melanoma	0.000177	0.00138	CbGpPWpGaD
Tranexamic Acid—Vomiting—Temozolomide—melanoma	0.000173	0.00254	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MDM2—melanoma	0.000173	0.00135	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HDAC2—melanoma	0.000172	0.00135	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF1—melanoma	0.000172	0.00135	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000171	0.00134	CbGpPWpGaD
Tranexamic Acid—Headache—Temozolomide—melanoma	0.000171	0.0025	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—melanoma	0.00017	0.00133	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FN1—melanoma	0.00017	0.00133	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GNAQ—melanoma	0.00017	0.00133	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD44—melanoma	0.00017	0.00133	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITGA4—melanoma	0.00017	0.00133	CbGpPWpGaD
Tranexamic Acid—Hypotension—Docetaxel—melanoma	0.000169	0.00248	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM1—melanoma	0.000169	0.00133	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IFNB1—melanoma	0.000169	0.00132	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—melanoma	0.000168	0.00132	CbGpPWpGaD
Tranexamic Acid—Nausea—Carmustine—melanoma	0.000168	0.00245	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—melanoma	0.000165	0.00242	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—melanoma	0.000165	0.00129	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IFNA1—melanoma	0.000165	0.00129	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—melanoma	0.000163	0.00128	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—melanoma	0.000162	0.00127	CbGpPWpGaD
Tranexamic Acid—Nausea—Temozolomide—melanoma	0.000162	0.00237	CcSEcCtD
Tranexamic Acid—Dyspnoea—Docetaxel—melanoma	0.000162	0.00237	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SYK—melanoma	0.00016	0.00125	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Docetaxel—melanoma	0.00016	0.00234	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—melanoma	0.000158	0.00124	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITGAV—melanoma	0.000157	0.00123	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT3—melanoma	0.000157	0.00123	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—melanoma	0.000157	0.00229	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—melanoma	0.000156	0.00229	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IFNA2—melanoma	0.000153	0.0012	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—PAX6—melanoma	0.000153	0.0012	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000152	0.00119	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—melanoma	0.00015	0.00117	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Docetaxel—melanoma	0.000149	0.00219	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—melanoma	0.000148	0.00217	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—HSPA5—melanoma	0.000147	0.00115	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1A—melanoma	0.000145	0.00114	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—melanoma	0.000145	0.00114	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—melanoma	0.000144	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—melanoma	0.000144	0.00113	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Docetaxel—melanoma	0.000143	0.0021	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ITGB1—melanoma	0.000142	0.00112	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PLCB4—melanoma	0.000139	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL1—melanoma	0.000139	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FGF2—melanoma	0.000137	0.00107	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Docetaxel—melanoma	0.000134	0.00196	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—melanoma	0.000132	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TRRAP—melanoma	0.00013	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CUL3—melanoma	0.00013	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HGF—melanoma	0.00013	0.00102	CbGpPWpGaD
Tranexamic Acid—Asthenia—Docetaxel—melanoma	0.00013	0.00191	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—melanoma	0.00013	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—NRAS—melanoma	0.000129	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CSF2—melanoma	0.000129	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKR1B10—melanoma	0.000127	0.000994	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Docetaxel—melanoma	0.000124	0.00182	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—melanoma	0.000124	0.000972	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITGB3—melanoma	0.000123	0.000968	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKCA—melanoma	0.000123	0.000968	CbGpPWpGaD
Tranexamic Acid—Dizziness—Docetaxel—melanoma	0.00012	0.00176	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK1—melanoma	0.000118	0.000925	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—F2RL1—melanoma	0.000118	0.000925	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—melanoma	0.000118	0.000924	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCB1—melanoma	0.000116	0.00091	CbGpPWpGaD
Tranexamic Acid—Vomiting—Docetaxel—melanoma	0.000115	0.00169	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—melanoma	0.000115	0.000899	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAC1—melanoma	0.000114	0.000897	CbGpPWpGaD
Tranexamic Acid—Headache—Docetaxel—melanoma	0.000114	0.00166	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—melanoma	0.000112	0.000879	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—melanoma	0.000111	0.000873	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRM3—melanoma	0.000111	0.000869	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MMP1—melanoma	0.000111	0.000868	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CDK2—melanoma	0.000109	0.000852	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—melanoma	0.000108	0.000849	CbGpPWpGaD
Tranexamic Acid—Nausea—Docetaxel—melanoma	0.000108	0.00158	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—melanoma	0.000106	0.000832	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KISS1—melanoma	0.000105	0.000824	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—melanoma	0.000102	0.000802	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SKI—melanoma	0.000102	0.000798	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR1—melanoma	0.000102	0.000798	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FN1—melanoma	0.000101	0.000792	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—melanoma	0.000101	0.000792	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MC1R—melanoma	0.0001	0.000786	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NOS2—melanoma	9.98e-05	0.000783	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—melanoma	9.67e-05	0.000758	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRM1—melanoma	9.61e-05	0.000754	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCR7—melanoma	9.61e-05	0.000754	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—EGF—melanoma	9.56e-05	0.000749	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—melanoma	9.47e-05	0.000742	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SUFU—melanoma	9.37e-05	0.000734	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—melanoma	9.06e-05	0.00071	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IGF1—melanoma	8.85e-05	0.000694	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—melanoma	8.76e-05	0.000687	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RHOB—melanoma	8.75e-05	0.000686	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BCL2L11—melanoma	8.75e-05	0.000686	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP1—melanoma	8.71e-05	0.000683	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	8.69e-05	0.000681	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—melanoma	8.5e-05	0.000666	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HDAC6—melanoma	8.4e-05	0.000659	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—melanoma	8.39e-05	0.000658	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—melanoma	8.36e-05	0.000655	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	8.16e-05	0.00064	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR2—melanoma	7.97e-05	0.000624	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAC2—melanoma	7.84e-05	0.000614	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—WNT5A—melanoma	7.71e-05	0.000605	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFC—melanoma	7.71e-05	0.000605	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—melanoma	7.41e-05	0.000581	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—melanoma	7.26e-05	0.000569	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—melanoma	7.16e-05	0.000561	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGF1—melanoma	6.96e-05	0.000546	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL2—melanoma	6.8e-05	0.000533	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—F2R—melanoma	6.77e-05	0.000531	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—melanoma	6.74e-05	0.000528	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	6.63e-05	0.00052	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDNRB—melanoma	6.56e-05	0.000514	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTK2B—melanoma	6.37e-05	0.000499	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GNA11—melanoma	6.19e-05	0.000486	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GAB2—melanoma	6.19e-05	0.000486	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FLT1—melanoma	6.17e-05	0.000484	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR4—melanoma	5.82e-05	0.000457	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HDAC2—melanoma	5.82e-05	0.000457	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FOXO4—melanoma	5.82e-05	0.000457	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—melanoma	5.78e-05	0.000453	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GNAQ—melanoma	5.76e-05	0.000451	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NRAS—melanoma	5.71e-05	0.000448	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—melanoma	5.6e-05	0.000439	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK3—melanoma	5.47e-05	0.000429	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SYK—melanoma	5.41e-05	0.000424	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ITGAV—melanoma	5.31e-05	0.000417	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT3—melanoma	5.31e-05	0.000417	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NGFR—melanoma	5.31e-05	0.000417	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK1—melanoma	5.2e-05	0.000408	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTNNB1—melanoma	5.17e-05	0.000405	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SOCS1—melanoma	4.92e-05	0.000386	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KRAS—melanoma	4.92e-05	0.000385	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—S100B—melanoma	4.91e-05	0.000385	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB4—melanoma	4.69e-05	0.000368	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN2B—melanoma	4.65e-05	0.000365	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—melanoma	4.52e-05	0.000354	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CD86—melanoma	4.5e-05	0.000353	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDN1—melanoma	4.47e-05	0.00035	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—melanoma	4.37e-05	0.000342	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CSF2—melanoma	4.36e-05	0.000342	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF1—melanoma	4.36e-05	0.000342	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—E2F1—melanoma	4.27e-05	0.000335	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDGFRA—melanoma	4.23e-05	0.000331	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKCA—melanoma	4.18e-05	0.000328	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ITGB3—melanoma	4.18e-05	0.000328	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HRAS—melanoma	4.18e-05	0.000328	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	4.15e-05	0.000325	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPP1—melanoma	4.1e-05	0.000322	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAP2K2—melanoma	4.09e-05	0.000321	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TERT—melanoma	3.89e-05	0.000305	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAC1—melanoma	3.88e-05	0.000304	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—melanoma	3.72e-05	0.000292	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—melanoma	3.69e-05	0.000289	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KDR—melanoma	3.56e-05	0.000279	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FN1—melanoma	3.42e-05	0.000268	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH1—melanoma	3.35e-05	0.000263	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CD80—melanoma	3.28e-05	0.000257	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIT—melanoma	3.28e-05	0.000257	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—melanoma	3.28e-05	0.000257	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—melanoma	3.28e-05	0.000257	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGF—melanoma	3.24e-05	0.000254	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BRAF—melanoma	3.08e-05	0.000242	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1—melanoma	3e-05	0.000235	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAP2K1—melanoma	2.9e-05	0.000227	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—melanoma	2.88e-05	0.000226	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF2—melanoma	2.76e-05	0.000216	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—melanoma	2.58e-05	0.000202	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—melanoma	2.54e-05	0.0002	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—melanoma	2.51e-05	0.000197	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—melanoma	2.41e-05	0.000189	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—melanoma	2.36e-05	0.000185	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—melanoma	2.31e-05	0.000181	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—melanoma	2.31e-05	0.000181	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—melanoma	2.25e-05	0.000176	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTNNB1—melanoma	2.23e-05	0.000175	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—melanoma	2.18e-05	0.000171	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1A—melanoma	2.18e-05	0.000171	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—melanoma	2.17e-05	0.00017	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NFKB1—melanoma	2.16e-05	0.000169	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—melanoma	1.96e-05	0.000154	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—melanoma	1.94e-05	0.000152	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NRAS—melanoma	1.94e-05	0.000152	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—melanoma	1.85e-05	0.000145	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—melanoma	1.8e-05	0.000141	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK1—melanoma	1.76e-05	0.000138	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—melanoma	1.76e-05	0.000138	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—melanoma	1.67e-05	0.000131	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—melanoma	1.53e-05	0.00012	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—melanoma	1.48e-05	0.000116	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—melanoma	1.42e-05	0.000111	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—melanoma	1.36e-05	0.000106	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—melanoma	1.25e-05	9.8e-05	CbGpPWpGaD
